Viaderma Inc. logo

Viaderma Inc. (VDRM)

Market Closed
5 Dec, 14:31
OTC PINK OTC PINK
$
0. 00
-0
-50%
$
1.23M Market Cap
0.04 P/E Ratio
0% Div Yield
490,000 Volume
0 Eps
$ 0
Previous Close
Day Range
0 0
Year Range
0 0.02
Want to track VDRM and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

VDRM closed Friday lower at $0, a decrease of 50% from Thursday's close, completing a monthly increase of 0% or $0. Over the past 12 months, VDRM stock lost -98.57%.
VDRM is not paying dividends to its shareholders.
The last earnings report, released on Mar 31, 2025, exceeded the consensus estimates by 0%. On average, the company has fell short of earnings expectations by 0%, based on the last three reports.
Viaderma Inc. has completed 3 stock splits, with the recent split occurring on May 06, 2014.
The company's stock is traded on 1 different exchanges and in various currencies, with the primary listing on OTC PINK (USD).

VDRM Chart

Viaderma Inc. (VDRM) FAQ

What is the stock price today?

The current price is $0.00.

On which exchange is it traded?

Viaderma Inc. is listed on OTC PINK.

What is its stock symbol?

The ticker symbol is VDRM.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 0%.

What is its market cap?

As of today, the market cap is 1.23M.

Has Viaderma Inc. ever had a stock split?

Viaderma Inc. had 3 splits and the recent split was on May 06, 2014.

Viaderma Inc. Profile

Specialty Retail Industry
Consumer Discretionary Sector
Dr. Christopher A Otiko CEO
OTC PINK Exchange
US92555K1016 ISIN
US Country
- Employees
- Last Dividend
6 May 2014 Last Split
- IPO Date

Overview

ViaDerma, Inc. is a specialty pharmaceutical company based in the United States, concentrating on the development and marketing of pharmaceutical products and the licensing of its technology to other companies within the pharmaceutical industry across various therapeutic areas. Initially known as Décor Products International, Inc., the company underwent a name change to ViaDerma, Inc. in May 2014. Since its incorporation in 2007, it has been stationed in Marina Del Rey, California, dedicating its efforts to introducing innovative products in the medical field.

Products and Services

Below is a detailed look at ViaDerma, Inc.'s extensive range of products and services:

  • Vitastem: This tetracycline-based topical antibiotic represents the company's flagship product. It is designed for the treatment of various skin conditions, including cuts, scrapes, wounds, infections, burns, acne, psoriasis, eczema, and minor injuries, showcasing the company's commitment to contributing significant solutions in the topical medication market.
  • Topical Antibiotics: Continuing its focus on skin health, ViaDerma is developing additional topical antibiotics aimed at treating and managing skin infections, further emphasizing its role in advancing dermatological care.
  • Toenail Antifungal Drugs: Diving into the specific area of fungal infections, the company is working on toenail antifungal drugs to address a common yet often difficult to treat condition, marking its presence in the sector of specialized foot care.
  • Diabetic Amputations: ViaDerma is also in the process of creating solutions aimed at the prevention or treatment of infections leading to diabetic amputations, highlighting its dedication to addressing critical health issues faced by diabetic patients.
  • Global Acne, Psoriasis, and Eczema Products: The company's research and development efforts extend to crafting treatments for widespread dermatological conditions such as acne, psoriasis, and eczema, showcasing its determination to improve skin health on a global scale.
  • Burns: Products for the treatment of burns are also part of ViaDerma's portfolio, which is aimed at aiding in the recovery and healing process of such injuries, reinforcing its commitment to comprehensive skin injury recovery.
  • Anti-Aging/Wrinkle Remover Creams: Further expanding its dermatological reach, ViaDerma is exploring the anti-aging market with the development of creams targeted at reducing wrinkles and reversing signs of aging, catering to the cosmetic aspect of skin care.
  • Medical Cannabis: The company is tapping into the burgeoning field of medical cannabis, developing products that could potentially offer relief for various conditions, illustrating its adaptability to emerging trends in health care.
  • Male-Pattern Baldness: Addressing another common concern, ViaDerma is working on treatments for male-pattern baldness, aiming to contribute solutions in the area of hair loss.
  • Skin Cancer: Reflecting its commitment to combating serious health issues, the company is developing products aimed at the treatment of skin cancer, one of the most prevalent forms of cancer worldwide.
  • Erectile Dysfunction: ViaDerma is not limited to dermatological and cosmetic concerns, as it is also developing solutions for erectile dysfunction, thus addressing important aspects of men's health.
  • Pain Management: Finally, the company’s portfolio includes efforts in the area of pain management, aiming to provide relief and improve the quality of life for individuals suffering from chronic pain.

Contact Information

Address: 4640 Admiralty Way
Phone: 310 496 5744